Label: NICOMIDE- niacinamide, zinc glycinate, folic acid, cupric oxide, selenium and chromium tablet
- NDC Code(s): 75854-343-60
- Packager: Avion Pharmaceuticals, LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated October 11, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
STATEMENT OF IDENTITY
Rx Only Dietary Supplement
DESCRIPTION
Nicomide® Tablets is a prescription dietary supplement for oral administration, specifically formulated for the dietary management of patients with unique nutritional needs who require increased levels of one or more of the ingredients in this product. Each white-colored, oval-shaped tablet is debossed with 342 on one side and blank on the other.
Supplement Facts Serving Size: 1 Tablet Amount per serving: % Daily Value Niacinamide 750 mg † Zinc (as Zinc Bisglycinate Chelate)* 27 mg 180% Folate (as (6S)-N5-Methyltetrahydrofolic Acid Calcium Salt) 500 mcg 125% Copper (as Cupric Oxide) 100% Selenium (Selenium Amino Acid Chelate) 71% Chromium (Chromium Amino Acid Chelate) 83% † Daily Value (DV) not established. OTHER INGREDIENTS
Methocel K, Lactose Anhydrous, Silicon Dioxide, Stearic Acid, Microcrystalline Cellulose, Magnesium Stearate, Hydroxypropyl Methylcellulose, Triacetin, and Titanium Dioxide.
INDICATIONS
Nicomide® Tablets is indicated for use as a dietary supplement for patients who are deficient in, or who are at risk for deficiency in one or more of the ingredients in this product.
CONTRAINDICATIONS
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
-
PRECAUTIONS
PRECAUTIONS
Large doses of Nicomide® Tablets should be administered with caution in patients with a history of jaundice, liver disease, or diabetes. Patients with chronic liver failure and/or renal failure should exercise extreme caution in taking prescribed supplements containing copper.
Folic acid alone is improper treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid especially in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission may occur while neurological manifestations remain progressive.
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
-
WARNINGS
WARNINGS
If you are pregnant, nursing, or taking medication, consult your doctor before use. Use only under the advice and supervision of a physician if you have a history of jaundice, liver disease or diabetes. Abnormal liver function tests have been reported in persons taking daily doses of 500 mg or more of niacinamide. Folate intake should not exceed 250% of the Daily Value (1,000 mcg).
PREGNANCY & NURSING MOTHERS
Nicomide® Tablets is not indicated for use as a prenatal/postnatal multivitamin for lactating and nonlactating mothers. Physicians and medical practitioners should administer Nicomide® Tablets with caution to patients who are pregnant, lactating and/or taking medication.
ADVERSE REACTIONS
Allergic sensitization has been reported rarely following oral and parental administration of Folate. -
DOSAGE & ADMINISTRATION
DOSAGE AND ADMINISTRATION
Take 1-2 tablets daily, as a dietary supplement, as directed by your physician.
HOW SUPPLIED
Nicomide® Tablets are white-colored, oval-shaped tablets debossed on one side with “342”, and are supplied in bottles of 60 tablets (75854-343-60). The listed product number is not a National Drug Code. Instead, Avion has assigned a product code formatted according to standard industry practice in order to comply with the formatting requirements of pharmacy and healthcare insurance computer systems.
STORAGE
Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.]
MANUFACTURED FOR:
Avion Pharmaceuticals, LLC
Alpharetta, GA 30022
1-888-61-AVION
Rev. 1117-01*Subject to one or more claims of U.S. Patent Nos. 7,582,418, 7,838,042 and 8,425,956.
Nicomide® is a registered trademark of Acella Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
NICOMIDE
niacinamide, zinc glycinate, folic acid, cupric oxide, selenium and chromium tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:75854-343 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 750 mg ZINC GLYCINATE (UNII: 681VJX72FE) (ZINC CATION - UNII:13S1S8SF37) ZINC GLYCINATE 27 mg FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID 500 ug CUPRIC OXIDE (UNII: V1XJQ704R4) (CUPRIC CATION - UNII:8CBV67279L) CUPRIC CATION 2 mg SELENIUM (UNII: H6241UJ22B) (SELENIUM - UNII:H6241UJ22B) SELENIUM 50 ug CHROMIUM (UNII: 0R0008Q3JB) (CHROMIUM - UNII:0R0008Q3JB) CHROMIUM 100 ug Inactive Ingredients Ingredient Name Strength HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K) ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID (UNII: 4ELV7Z65AP) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) MAGNESIUM STEARATE (UNII: 70097M6I30) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) TRIACETIN (UNII: XHX3C3X673) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color WHITE Score no score Shape OVAL Size 23mm Flavor Imprint Code 342 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:75854-343-60 60 in 1 BOTTLE; Type 0: Not a Combination Product 12/08/2014 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 12/08/2014 Labeler - Avion Pharmaceuticals, LLC (040348516) Registrant - Avion Pharmaceuticals, LLC (040348516) Establishment Name Address ID/FEI Business Operations Avion Pharmaceuticals, LLC 040348516 manufacture(75854-343)